1. Home
  2. EYPT

EYPT

EyePoint Pharmaceuticals Inc.

Logo EyePoint Pharmaceuticals Inc.

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

as 04-19-2024 2:30pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Founded: 1987 Country:
United States
United States
Employees: N/A City: WATERTOWN
Market Cap: 1.1B IPO Year: 2005
Target Price: $35.63 AVG Volume (30 days): 927.0K
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.82 EPS Growth: N/A
52 Week Low/High: $3.71 - $30.99 Next Earning Date: 05-01-2024
Revenue: $46,018,000 Revenue Growth: 11.14%
Revenue Growth (this year): -16.68% Revenue Growth (next year): -69.59%

Share on Social Networks: